Sensus Healthcare, Inc. financial data

Symbol
SRTS on Nasdaq
Location
Boca Raton, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 826% % -24%
Quick Ratio 176% % -33%
Debt-to-equity 13% % 22%
Return On Equity -6% % -131%
Return On Assets -5% % -131%
Operating Margin -15% % -153%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16,425,036 shares 0.21%
Common Stock, Shares, Outstanding 16,440,036 shares 0.3%
Entity Public Float $79,995,039 USD 75%
Common Stock, Value, Issued $169,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 16,320,036 shares -0.01%
Weighted Average Number of Shares Outstanding, Diluted 16,320,036 shares -0.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $35,609,000 USD -14%
Revenue from Contract with Customer, Excluding Assessed Tax $35,609,000 USD -22%
Cost of Revenue $3,599,000 USD 89%
Research and Development Expense $7,457,000 USD 124%
Selling and Marketing Expense $6,524,000 USD 55%
General and Administrative Expense $5,683,000 USD 0.62%
Operating Income (Loss) $5,432,000 USD -145%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,675,000 USD -136%
Income Tax Expense (Benefit) $1,669,000 USD -147%
Net Income (Loss) Attributable to Parent $3,006,000 USD -132%
Earnings Per Share, Basic 0 USD/shares -132%
Earnings Per Share, Diluted 0 USD/shares -132%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $24,453,000 USD 8.4%
Accounts Receivable, after Allowance for Credit Loss, Current $9,336,000 USD -45%
Inventory, Net $13,040,000 USD 9%
Other Assets, Current $2,035,000 USD 28%
Assets, Current $50,205,000 USD -8.4%
Deferred Income Tax Assets, Net $4,237,000 USD 93%
Property, Plant and Equipment, Net $2,522,000 USD 54%
Operating Lease, Right-of-Use Asset $513,000 USD -19%
Other Assets, Noncurrent $818,000 USD 39%
Assets $58,295,000 USD -2.6%
Contract with Customer, Liability, Current $686,000 USD
Liabilities, Current $6,803,000 USD 31%
Contract with Customer, Liability, Noncurrent $66,000 USD
Operating Lease, Liability, Noncurrent $277,000 USD -39%
Liabilities $7,101,000 USD 24%
Retained Earnings (Accumulated Deficit) $8,882,000 USD -25%
Stockholders' Equity Attributable to Parent $51,194,000 USD -5.4%
Liabilities and Equity $58,295,000 USD -2.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,677,000 USD 67%
Net Cash Provided by (Used in) Financing Activities $300,000 USD
Net Cash Provided by (Used in) Investing Activities $7,000 USD 97%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 17,031,845 shares 0.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24,453,000 USD 8.4%
Deferred Tax Assets, Valuation Allowance $185,000 USD 0%
Deferred Tax Assets, Gross $2,403,000 USD 2.6%
Operating Lease, Liability $534,000 USD -18%
Depreciation $329,000 USD 76%
Payments to Acquire Property, Plant, and Equipment $7,000 USD -97%
Lessee, Operating Lease, Liability, to be Paid $565,000 USD -20%
Property, Plant and Equipment, Gross $4,685,000 USD 36%
Operating Lease, Liability, Current $257,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year Two $214,000 USD -9.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $281,000 USD 23%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) $110,000 USD -87%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $31,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid, Year Three $181,000 USD -23%
Deferred Tax Assets, Operating Loss Carryforwards $647,000 USD -21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $46,014,000 USD 0.82%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,218,000 USD 2.8%
Share-based Payment Arrangement, Expense $5,000 USD -64%
Interest Expense $183,000 USD 12%